Skip to content

Marcus Hompesch

  • MD (Dr. med.)
  • CEO
  • ProSciento, Inc.
  • 20h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 1506CitationsNumber of citations received by Marcus's publications. Updated daily.

Recent publications

  • Single-dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK-1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjects

    • Crutchlow M
    • Palcza J
    • Mostoller K
    • et al.
    N/AReaders
    7Citations
  • alpha-Lipoic acid in NIDDM patients with cardiac autonomic neuropathy.

    • Köbberling J
    • Hompesch M
    N/AReaders
    0Citations

Professional experience

CEO

ProSciento, Inc.

January 2004 - Present

Co-authors (245)

Other IDs